Tue, Sep 16, 2014, 1:41 AM EDT - U.S. Markets open in 7 hrs 49 mins

Recent

% | $
Quotes you view appear here for quick access.

ADVANCED CELL TECH Message Board

loner4799 43 posts  |  Last Activity: 2 hours 26 minutes ago Member since: Jan 28, 2014
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • if ACTCD only treats 10% of that patient population
    The treated number will be 20,000,000 million ( twenty million )
    The cost per eye will be at least $ 10,000.00 dollars
    Total revenue $ 200,000,000,000 that is correct TWO HUNDRED TRILLION DOLLARS
    The company has stated that is costs $ 100.00 dollars to make a syringe full for an injection
    You always have other fixed and variable overhead, so say it's approx 35 %
    EARNINGS WOULD BE a WHOPPING $ 70,000,000,000 SEVENTY TRILLION
    total shares O/S NOW 33 million
    the PPS would then be $ 2,310,000,000,000,000,000
    YES that would be in profit TWO quintillion, three hundred and ten quadrillion, trillion, billlion, million, hundreds of thousandths, tens of thousands.
    THAT IS CORRECT!
    The point is that this company with better than curing safely, more than half of the patients will get early breakthrough designation, and will be able to start injections, waaaaay before phase 2 is in it's infancy; besides it's orphan drug status which allows 7 years of exclusivity. The profits are mind blowing, and if you think all we will get is 10% of the worlds population, you are mistaken. Out of common sense the P/E price to earnings would easily be a ratio of 15. If you want you can go find a scientific calendar and do the math. This stock will be the biggest stock EVER and it won't be long.

  • loner4799 loner4799 12 hours ago Flag

    it's irrelevant what you compare the large numbers to; it won't help your cause of shorting or bashing. Are you suggesting the cost won't be at least $10,0000 per eye, and we won't get 10 % market share. Okay chief why don't you explain what % we are going to get and how much per eye the treatment will be, this should be good for a big laugh

  • to come on board to a $ 300,000 dollar a year job, duhhh
    Facts; total AMD number in 2020 is 200,000,000 million people will need this treatment
    if ACTCD only treats 10% of that patient population
    The treated number will be 20,000,000 million ( twenty million )
    The cost per eye will be at least $ 10,000.00 dollars
    Total revenue $ 200,000,000,000 that is correct TWO HUNDRED TRILLION DOLLARS
    The company has stated that is costs $ 100.00 dollars to make a syringe full for an injection
    You always have other fixed and variable overhead, so say it's approx 35 %
    EARNINGS WOULD BE a WHOPPING $ 70,000,000,000 SEVENTY TRILLION
    total shares O/S NOW 33 million
    the PPS would then be $ 2,310,000,000,000,000,000
    YES that would be in profit TWO quintillion, three hundred and ten quadrillion, trillion, billlion, million, hundreds of thousandths, tens of thousands.
    THAT IS CORRECT!
    The point is that this company with better than curing safely, more than half of the patients will get early breakthrough designation, and will be able to start injections, waaaaay before phase 2 is in it's infancy; besides it's orphan drug status which allows 7 years of exclusivity. The profits are mind blowing, and if you think all we will get is 10% of the worlds population, you are mistaken. Out of common sense the P/E price to earnings would easily be a ratio of 15. If you want you can go find a scientific calendar and do the math. This stock will be the biggest stock EVER and it won't be long.

  • loner4799 loner4799 Sep 14, 2014 8:56 PM Flag

    it won't matter even if it drops to 10 cents the numbers are genuine, if you think they lied about curing the blind, then you should sue the co. the numbers are not only conservative IE 10 % then if you will sleep better then say only 2 % , there you feel better, and if that isn't enough say only 5 thousand an eye, there now you happy, you are still the richest top 2 % of the population even if you invest a thousand, wake up that is the real number, hey sell your shares I'll buy them

  • would be price per share , and not profit, my bad

  • Facts; total AMD number in 2020 is 200,000,000 million people will need this treatment
    if ACTCD only treats 10% of that patient population
    The treated number will be 20,000,000 million ( twenty million )
    The cost per eye will be at least $ 10,000.00 dollars
    Total revenue $ 200,000,000,000 that is correct TWO HUNDRED TRILLION DOLLARS
    The company has stated that is costs $ 100.00 dollars to make a syringe full for an injection
    You always have other fixed and variable overhead, so say it's approx 35 %
    EARNINGS WOULD BE a WHOPPING $ 70,000,000,000 SEVENTY TRILLION
    total shares O/S NOW 33 million
    the PPS would then be $ 2,310,000,000,000,000,000
    YES that would be in profit TWO quintillion, three hundred and ten quadrillion, trillion, billlion, million, hundreds of thousandths, tens of thousands.
    THAT IS CORRECT!
    The point is that this company with better than curing safely, more than half of the patients will get early breakthrough designation, and will be able to start injections, waaaaay before phase 2 is in it's infancy; besides it's orphan drug status which allows 7 years of exclusivity. The profits are mind blowing, and if you think all we will get is 10% of the worlds population, you are mistaken. Out of common sense the P/E price to earnings would easily be a ratio of 15. If you want you can go find a scientific calendar and do the math. This stock will be the biggest stock EVER and it won't be long.

  • loner4799 by loner4799 Sep 12, 2014 1:28 PM Flag

    tomorrow announcement of enrollment for MMD trials, Dr. Schwartz starts one week, only a 12 injection phase one, all doe at his hospital, all done projected 6 six weeks and we all know how fast it works, the cowboy went from 400/20 to 40/20 in a week. The data safety management board has approved safety, 7 times here, and in Europe, it's the same solution, so that's a no brainer. Efficacy will be the same the stuff works. ANOTHER 10's of BILLIONS in revenue, if they announce it you can bet real green on your portfolio , take a look it's on the website, tick tock tick tock
    jjeeezzzzz even seeking alpha just gave us an $ 83.00 near term pps we all know it's coming partnership, uplist and top line data, I still say $ 200.00 pps and bet me I will be right these big institutions will not sit back once we uplist, all stemillionaires very soon, if you own enough if not too bad for you

  • this is stilla low float, and these are in the future authorized shares, NOT outstanding shares, and the will if voted in be put to good use, sorry emotional sucjkers

  • the article will read ACTC screws the long term shareholders one more time, while the insiders sell , what a horrible company, they should be sued

  • this puppy drops back to $ 5.00 dollars or less in no time, this company is just trash and all the employees are #$%$, congratulations shorts make a killing

  • don't worry they are baggies for about 35 % still they will lose it back this week poor shorts

  • pay 12.20 now or at the days close you can buy your way out at 15.00, you decide how much you want to lose. Low float and everyone holding tight on their shares, and smart money wants in

    hehehe

  • 12.05 and 12.10 and already trading, either a smart buyer or the beginning of the naked short moles buried deep inside ACTC scurrying out, they, alone will sky rocket this thing, look at how much money they have already lost since the reverse, and today another beating they will buy buy buy their way out of losing a fortune, many will go completely broke, thye are hard headed and you can't fix stupid. I hope they get emotional and stay shorted up.

  • and real buyers that know what is about to happen. This rise won't stop till the meteoric rise on the uplist, and the jv announcement and the final top line data, enjoy the ride this will go for quite some time, $ 200.00 dollars here we come

  • we are just keep buying your way out of trouble, suckers

  • Reply to

    POOR SHEEPS GETIN SUCKERED IN AGAIN

    by am.udaddy Sep 10, 2014 12:06 AM
    loner4799 loner4799 Sep 10, 2014 12:24 AM Flag

    sorry your trapped shorty but it's all over for you

  • Reply to

    two thoughts

    by loner4799 Sep 9, 2014 11:11 PM
    loner4799 loner4799 Sep 9, 2014 11:35 PM Flag

    I know I'm right the old $ 2.00 dollars is so easy with so few shares available, and the demand so high, everyone knows what is about to happen, look what is happening with just retail investors since the reverse at 8 dollars we broke 12 today, and everyday till the whopper news and uplist and jv it will climb no one wants to miss this train. I know so many people that own a lot of shares and they have no intention of selling till they see 500 plus dollars a share, and even then they only will sell a partial of their holdings, everyone knows whats about to happen, stemillionaires everywhere

  • loner4799 by loner4799 Sep 9, 2014 11:11 PM Flag

    1) the shorts are really going to take a beating, literally everyday, and if they are naked after the uplist and all shares have to be accounted for, as the process has already started, whew, this stock on that alone will literally fly
    2) this steady rally up to the remarkable 3 pieces of news, should go to $ 20.00 or $ 30.00 dollars easy, there just isn't that much supply, what idiot would sell now???? And the supply is so miniscule.

    We have A) the uplist B) the JV and C) the TOP LINE DATA IN A PROF RESPECTED JOURNAL, hopefully the NEW ENGLAND JOURNAL OF MEDICINE

    If we get to 20 or 30 BEFOTRE these events ( and they should play out over the next 20 days ) with the foolish shorts, I see between $ 200.00 and $ 300.00 dollars per share.

    Even at 200 (x) 33 million o/s shares thats only a market cap of $ six billion six hundred million dollars, and the revenue from this disease is 55 billion a year. I might be low balling the number grossly

  • no lawsuits, no sec lawsuits, 40 million in cash reserves, 30 from lincoln, and Matt stated a month ago they had 13 million, NO DEBT except the small payouts over several years from the legacy issues, A REAL SMALL FLOAT, AND the best is there are shorts that are trapped, alon with the naked shorts, and bestest of all not too many shares available to trade, so demand high and supply low; and we haven't even broke the news, or uplisted, or JV"D. I say $ 500.00 dollars if you really know what's happening. Wait till the institutions start in, and they can't do anything with all their trillions of dollars until the uplist, it must be killing them

  • Even at $ 500.00 dollars a share that is only a market cap of 15 billion dollars. The market is a 55 billion dollar a year RECURRING REVENUE ; lets not forget this is a cure not a vaccination, so each year a % of the population acquires the disease, ONGOING, a never ending well to draw from, an eternal light. If they only charge $ 10,000.00 dollars per eye, and we already know from an earlier presentation with Dr. Lanza, the serum cost to produce is only $ 100.00 dollars , well you do the math, it's the cost of goods, plus the associated cost to get the injection to the hospital, or the outpatient smaller surgery centers. If you figure in the multiples that are usually attributed to stocks, $ 500.00 dollars on the one disease itself is brutally undervalued. This will be the biggest stock ever. There is no doubt in my mind. buy and hold, and you will be rich

ACTC
0.08150.0000(0.00%)Aug 27 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Avanir Pharmaceuticals, Inc.
NasdaqGSMon, Sep 15, 2014 4:00 PM EDT
21Vianet Group, Inc.
NasdaqGSMon, Sep 15, 2014 4:00 PM EDT
JDS Uniphase Corporation
NasdaqGSMon, Sep 15, 2014 4:15 PM EDT